A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients

Abstract

BioFibroScore is accurate to assess the stage of hepatic fibrosis in HCV-infected patients. Applying this noninvasive test can substantially reduce the need for invasive liver biopsy and can play a role for fibrosis evaluation when FibroScan assessment was unavailable or unreliable.